drugset / Trial / NCT00182741

Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer

NCT00182741

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Calcitriol may cause prostate cancer cells to look more like normal cells, and to grow and spread more slowly. Drugs used in chemotherapy, such as mitoxantrone and prednisone, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well giving calcitriol together with mitoxantrone and prednisone works in treating patients with metastatic prostate cancer.

Timeline

Start
2004-09
Primary completion
2006-08
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitriol Small molecule 180 ug Oral
Subject Mitoxantrone Small molecule 12 mg/m2 Intravenous
Subject Prednisone Other / unclassified 10 mg Oral

Indications